Total Payments
$11,366
2024 Payments
$706.58
Companies
8
Transactions
54
Medicare Patients
7,482
Medicare Billing
$600,241
Payment Breakdown by Category
Other$7,652 (67.3%)
Food & Beverage$2,606 (22.9%)
Consulting$1,000 (8.8%)
Education$108.44 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,652 | 1 | 67.3% |
| Food and Beverage | $2,606 | 50 | 22.9% |
| Consulting Fee | $1,000 | 1 | 8.8% |
| Education | $108.44 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis, Inc | $7,713 | 4 | $0 (2021) |
| ABBVIE INC. | $1,559 | 31 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,124 | 4 | $0 (2018) |
| Lumenis BE inc | $386.25 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $203.23 | 5 | $0 (2021) |
| GENZYME CORPORATION | $155.56 | 7 | $0 (2020) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $706.58 | 10 | ABBVIE INC. ($706.58) |
| 2023 | $466.66 | 7 | ABBVIE INC. ($466.66) |
| 2022 | $386.25 | 1 | Lumenis BE inc ($386.25) |
| 2021 | $78.60 | 4 | Lumenis, Inc ($61.15) |
| 2020 | $7,799 | 4 | Lumenis, Inc ($7,652) |
| 2019 | $250.09 | 3 | AbbVie, Inc. ($125.09) |
| 2018 | $1,530 | 17 | Galderma Laboratories, L.P. ($1,124) |
| 2017 | $148.75 | 8 | GENZYME CORPORATION ($66.14) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $118.64 | General |
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $120.13 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $78.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 01/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $72.22 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/14/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $110.41 | General |
| 11/16/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $134.73 | General |
| 09/30/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $83.34 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/02/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $86.35 | General |
| 05/01/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.52 | General |
| 02/24/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.44 | General |
| 05/09/2022 | Lumenis BE inc | OptiLight (Device) | Food and Beverage | Cash or cash equivalent | $386.25 | General |
| Category: Opthamology | ||||||
| 10/20/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2021 | Lumenis, Inc | Lumenis Pulse 120H (Device) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: Urology/Pelvic Health | ||||||
| 02/08/2021 | Lumenis, Inc | Lumenis Pulse 120H (Device) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Urology/Pelvic Health | ||||||
| 01/07/2021 | Lumenis, Inc | Lumenis Pulse 120H (Device) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Urology/Pelvic Health | ||||||
| 09/16/2020 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 09/10/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Immunology | ||||||
| 06/04/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,773 | 4,272 | $453,049 | $153,501 |
| 2022 | 19 | 1,964 | 4,543 | $471,313 | $156,686 |
| 2021 | 25 | 1,855 | 4,205 | $409,942 | $154,253 |
| 2020 | 22 | 1,890 | 4,094 | $392,830 | $135,801 |
Total Patients
7,482
Total Services
17,114
Medicare Billing
$600,241
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 367 | 590 | $140,420 | $52,477 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 291 | 371 | $62,328 | $22,657 | 36.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 89 | 128 | $44,800 | $14,334 | 32.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 267 | 321 | $43,335 | $13,499 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 244 | 2,094 | $43,974 | $10,574 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $25,370 | $9,091 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 105 | 105 | $20,370 | $7,587 | 37.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 79 | 84 | $18,984 | $6,652 | 35.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 61 | 66 | $15,246 | $4,747 | 31.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 35 | $12,425 | $4,242 | 34.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $4,901 | $1,773 | 36.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $5,291 | $1,419 | 26.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $3,960 | $1,396 | 35.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 25 | $2,775 | $980.32 | 35.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 17 | $2,125 | $703.25 | 33.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 24 | 57 | $2,679 | $589.95 | 22.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 24 | 62 | $2,170 | $471.82 | 21.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 18 | $828.00 | $182.88 | 22.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 29 | 178 | $1,068 | $126.44 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 520 | $123,760 | $43,950 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 339 | 427 | $71,736 | $25,166 | 35.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 87 | 117 | $37,206 | $13,417 | 36.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 296 | 344 | $46,440 | $13,149 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 157 | 157 | $30,458 | $12,310 | 40.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 272 | 2,163 | $45,423 | $11,186 | 24.6% |
About Dr. Steven Rasmussen, MD
Dr. Steven Rasmussen, MD is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679567937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Rasmussen, MD has received a total of $11,366 in payments from pharmaceutical and medical device companies, with $706.58 received in 2024. These payments were reported across 54 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,652).
As a Medicare-enrolled provider, Rasmussen has provided services to 7,482 Medicare beneficiaries, totaling 17,114 services with total Medicare billing of $600,241. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 09/01/2005
- Last Updated 06/05/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1679567937
Products in Payments
- EPIDUO FORTE (Drug) $1,113
- BOTOX (Biological) $512.83
- OptiLight (Device) $386.25
- Humira (Biological) $243.32
- COSENTYX (Biological) $203.23
- DUPIXENT (Biological) $146.80
- Biktarvy (Drug) $125.00
- DERMATITIS - DISEASE (Drug) $108.75
- Lumenis Pulse 120H (Device) $61.15
- SKYRIZI (Biological) $34.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608